Coming Soon: Drugs to Suit Your Genetic Profile (India)
This article was originally published in PharmAsia News
Indian scientist Sandeep Saxena has developed a new type of test that will allow doctors to adjust drug combinations and dosages to suit a particular patient's genetic profile. So far, Saxena's company, Acto Biotech, has already developed genetic testing for two essential drugs - six mercaypourine and five flurouracil. These two drugs are necessary to fight certain cancers and autoimmune disorders like rheumatoid arthritis. They can, however, result in high toxicity and serious side effects for some patients. Acton Biotech's genetic profiling will allow doctors to minimize toxicity and create the most efficient drug regimen for each patient. Researchers are hopeful that as more tests become available, genetically tailored medicine will help save lives by predicting drug reactions and creating personalized dosages. (Click here for more
You may also be interested in...
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.